XML 19 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues:        
Product sales, net $ 11,037 $ 0 $ 16,492 $ 0
Royalties 28,129 27,012 84,613 78,453
Sale of royalty rights 0 0 0 25,000
Other 36 7 36 7
Total revenues 39,202 27,019 101,141 103,460
Operating expenses:        
Cost of goods sold 1,077 0 1,615 0
Research and development 18,798 17,957 65,381 70,797
Selling, general and administrative 17,558 8,329 46,228 25,769
Total operating expenses 37,433 26,286 113,224 96,566
Operating income (loss) 1,769 733 (12,083) 6,894
Other income (expense)        
Interest income, net 108 64 221 224
Interest expense (2,959) (4,444) (9,388) (14,445)
Other (5) 323 (18) 795
Total other expense, net (2,856) (4,057) (9,185) (13,426)
Loss before income tax expense (1,087) (3,324) (21,268) (6,532)
Income tax expense 0 0 4 0
Net loss $ (1,087) $ (3,324) $ (21,272) $ (6,532)
Net loss per common and potential common share        
Basic $ (0.01) $ (0.04) $ (0.22) $ (0.08)
Diluted $ (0.01) $ (0.04) $ (0.22) $ (0.08)
Weighted average common and potential common shares outstanding        
Basic 102,227 86,947 96,034 86,910
Diluted 102,227 86,947 96,034 86,910